WinstonWınston
Back
Ardent Health logo

Ardent Health

ARDT
49
Medical - Care Facilities · Healthcare
Price
$10.99
+0.51 (+4.87%)
Market Cap
$1.58B
Winston Score
49
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Strong
Stability
Strong
Valuation
Strong

Share count falling — buybacks

1.3% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 143.3M (2021) → 141.5M (2025)

Winston Score History

The full picture

Ardent Health Partners runs a network of hospitals and outpatient clinics across the United States. It provides medical care to patients — things like emergency services, surgeries, and routine health visits. The company operates in several states, mostly in smaller and mid-sized markets where it is often one of the few major hospital systems in the area.

Ardent makes money by billing patients, private insurance companies, and government programs like Medicare and Medicaid for the medical services it provides. The company operates roughly 30 hospitals, primarily in states like Oklahoma, Texas, New Mexico, and Kansas. Its competitive position comes partly from being a dominant provider in regional markets where there is less competition from large national hospital chains. The main risk Ardent faces is that a large portion of its revenue depends on government reimbursement rates, which can be cut or changed by policy decisions outside the company's control.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-1.4% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-76.9% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

84.4%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$724M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Ardent Health's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
6.0%
Thin — 6.0% gross margin
Profit after running costs
Operating Margin
2.7%
Thin — 2.7% operating margin
Return on the money invested
ROCE
19.7%
Strong — 19.7% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+3.3%
Slow sales growth (+3.3% YoY)
Profit growth
EPS YoY
-69.6%
Earnings shrinking (-69.6% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
575%
Turns 575% of profit into real cash
Spare cash per sale
FCF Margin
3.3%
Thin free cash flow (3.3%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.82
Moderate — manageable debt (0.82)
Covers its interest
Interest Cover
9.74x
Comfortably covers interest (9.7x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
20.0x
Fair value — P/E 20.0

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+8.7
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (20.0 → 11.3)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial